NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The media has policies about covering penny stocks and OTC stocks if they are unknown Penny stocks as a general rule. But they now seem really in oncology to apply the same rule across the board. They used to tell you which company and include their ticker. Today, even if it’s a big they often bury the name if they say it at all. It’s up to investors who are interested to figure out what drug and who makes it.

They’ve stopped promoting the companies in their reporting in breakthrough drugs. Adam’s bashing of companies in his coverage is therefore quite out of sync with general trends, I believe. There are a few other like him and some aspirants at Seeking Alpha. It’s deeply unethical in my view, but that makes him in theory a financial writer, not really a biotech writer, though he pretends to be a biotech writer which gives him more credibility with the unwitting. Very problematic.